Targeting programmed cell death 1 receptor (PD-1) expression in lung cancer using a humanized mouse model

被引：0
|
作者：
Jiang, Dawei [1 ]
England, Christopher [1 ]
Ehlerding, Emily [1 ]
Graves, Stephen [2 ]
Hernandez, Reinier [1 ]
Cai, Weibo [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
179
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Role of Programmed Cell Death-1 (PD-1) and Its Ligands in Pediatric Cancer
    van Dam, Laura S.
    de Zwart, Verena M.
    Meyer-Wentrup, Friederike A. G.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 190 - 197
  • [42] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [43] Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms
    Wang, Jen-Chin
    Chen, Chi
    Kundra, Ajay
    Kodali, Sreenath
    Pandey, Anita
    Wong, Ching
    Cheung, Tony
    Gotlieb, Vladimir
    Joseph, Gardith
    Tribie, Sophia
    LEUKEMIA RESEARCH, 2019, 79 : 52 - 59
  • [44] Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
    Mallett, Grace
    Laurence, Arian
    Amarnath, Shoba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [45] Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway
    Momtaz, Parisa
    Postow, Michael A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 357 - 365
  • [46] Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients
    Pawlowska, Anna
    Suszczyk, Dorota
    Tarkowski, Rafal
    Paduch, Roman
    Kotarski, Jan
    Wertel, Iwona
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 9691 - 9709
  • [47] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [48] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
  • [49] Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
    Berntsson, Jonna
    Eberhard, Jakob
    Nodin, Bjorn
    Leandersson, Karin
    Larsson, Anna H.
    Jirstrom, Karin
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [50] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
12345